BR0108080A - Preparação de formas de dosagem de solução clara aquosa com ácidos biliares - Google Patents
Preparação de formas de dosagem de solução clara aquosa com ácidos biliaresInfo
- Publication number
- BR0108080A BR0108080A BR0108080-6A BR0108080A BR0108080A BR 0108080 A BR0108080 A BR 0108080A BR 0108080 A BR0108080 A BR 0108080A BR 0108080 A BR0108080 A BR 0108080A
- Authority
- BR
- Brazil
- Prior art keywords
- bile acid
- aqueous
- solution
- preparation
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
Abstract
"PREPARAçãO DE FORMAS DE DOSAGEM DE SOLUçãO CLARA AQUOSA COM áCIDOS BILIARES". Composições para usos farmacêuticos e para outros usos, compreendendo soluções aquosas claras de ácidos biliares, que não formam precipitados detectáveis sobre faixas selecionadas de valores de pH da solução aquosa, e processos de preparação de tais soluções. As composições da invenção compreendem água, um ácido biliar na forma de um ácido biliar, sal de ácido biliar ou de um ácido biliar conjugado com uma amina por uma ligação amida, e cada um ou ambos de um produto de conversão de amido solúvel aquoso e um polissacarídeo de não amido solúvel aquoso. A composição permanece em solução sem formar um precipitado sobre uma faixa de valores de pH e, de acordo com uma concretização, permanece em solução em todos os valores de pH obteníveis em um sistema aquoso. A composição, de acordo com algumas concretizações, pode conter adicionalmente um composto farmacêutico em uma quantidade farmaceuticamente eficaz. Exemplos não limitantes de compostos farmacêuticos incluem insulina, heparina, compostos de bismuto, amantadina e rimantadina.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18026800P | 2000-02-04 | 2000-02-04 | |
PCT/US2001/003745 WO2001056547A2 (en) | 2000-02-04 | 2001-02-05 | Preparation of aqueous clear solution dosage forms with bile acids |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0108080A true BR0108080A (pt) | 2006-02-07 |
Family
ID=22659829
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0108080-6A BR0108080A (pt) | 2000-02-04 | 2001-02-05 | Preparação de formas de dosagem de solução clara aquosa com ácidos biliares |
Country Status (11)
Country | Link |
---|---|
US (1) | US7166299B2 (pt) |
EP (1) | EP1255566A2 (pt) |
JP (1) | JP2004500378A (pt) |
KR (1) | KR100848344B1 (pt) |
CN (1) | CN100558407C (pt) |
AU (2) | AU3668501A (pt) |
BR (1) | BR0108080A (pt) |
CA (1) | CA2406930C (pt) |
IL (2) | IL150952A0 (pt) |
RU (1) | RU2277913C2 (pt) |
WO (1) | WO2001056547A2 (pt) |
Families Citing this family (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070072828A1 (en) * | 1998-07-24 | 2007-03-29 | Yoo Seo H | Bile preparations for colorectal disorders |
US7772220B2 (en) * | 2004-10-15 | 2010-08-10 | Seo Hong Yoo | Methods and compositions for reducing toxicity of a pharmaceutical compound |
US7303768B2 (en) * | 1998-07-24 | 2007-12-04 | Seo Hong Yoo | Preparation of aqueous clear solution dosage forms with bile acids |
US20050158408A1 (en) * | 1998-07-24 | 2005-07-21 | Yoo Seo H. | Dried forms of aqueous solubilized bile acid dosage formulation: preparation and uses thereof |
CA2426925A1 (en) * | 2000-11-24 | 2003-04-25 | Yamanouchi Pharmaceutical Co., Ltd. | Water-soluble liquid internal medicine |
KR20030082053A (ko) * | 2002-04-16 | 2003-10-22 | 진갑덕 | 담염(膽鹽)을 함유한 치약 조성물 |
AU2003900096A0 (en) * | 2003-01-10 | 2003-02-20 | Nature Vet | Orally deliverable pharmaceutical composition protein pump inhibitors |
US7145125B2 (en) | 2003-06-23 | 2006-12-05 | Advanced Optical Technologies, Llc | Integrating chamber cone light using LED sources |
US20050053664A1 (en) | 2003-09-08 | 2005-03-10 | Eliezer Zomer | Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer |
EP2422789B1 (en) * | 2004-05-19 | 2017-11-22 | Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center | Injectable coposition comprising sodium deoxycholate |
US7754230B2 (en) * | 2004-05-19 | 2010-07-13 | The Regents Of The University Of California | Methods and related compositions for reduction of fat |
US20060127468A1 (en) | 2004-05-19 | 2006-06-15 | Kolodney Michael S | Methods and related compositions for reduction of fat and skin tightening |
JP2008511651A (ja) * | 2004-08-30 | 2008-04-17 | セオ ホン ユー | 局所虚血モデルでの可溶化udcaの神経保護効果 |
BRPI0518191A (pt) | 2004-10-15 | 2008-11-04 | Seo Hong Yoo | métodos e composições para reduzir a toxicidade de um composto farmacêutico |
ES2358089T3 (es) * | 2004-11-01 | 2011-05-05 | Seo Hong Yoo | Métodos y composiciones para reducir la neurodegeneración en esclerosis lateral amiotrófica. |
CA2585471A1 (en) * | 2004-11-01 | 2006-05-11 | Seo Hong Yoo | Methods and compositions for reducing neurodegeneration in amyotrophic lateral sclerosis |
AU2004325203A1 (en) * | 2004-11-24 | 2006-06-01 | Seo Hong Yoo | Dried forms of aqueous solubilized bile acid dosage formulation: preparation and uses thereof |
WO2007022105A2 (en) | 2005-08-12 | 2007-02-22 | Rubicon Research Pvt. Ltd. | Stable pharmaceutical compositions, processes for making the same, and methods of their use |
WO2008011216A2 (en) | 2006-05-16 | 2008-01-24 | Pro-Pharmaceuticals, Inc. | Galactose-pronged polysaccharides in a formulation for antifibrotic therapies |
JP2010503667A (ja) * | 2006-09-15 | 2010-02-04 | ホン ユー,ソ | 大腸疾患用胆汁製剤 |
US8242294B2 (en) | 2007-06-19 | 2012-08-14 | Kythera Biopharmaceuticals, Inc. | Synthetic bile acid compositions and methods |
US20080318870A1 (en) | 2007-06-19 | 2008-12-25 | Kythera Biopharmaceuticals, Inc. | Synthetic bile acid compositions and methods |
JOP20180077A1 (ar) | 2007-06-19 | 2019-01-30 | Kythera Biopharmaceuticals Inc | تركيبات وطرق لحمض صفراوي تخليقي |
BRPI0822449A2 (pt) | 2008-03-04 | 2015-06-16 | Aleksander Vladimirovich Dikovskiy | Composição farmacêutica com base em hepatoprotetor e prebiótico, a produção e uso desta |
US8101593B2 (en) | 2009-03-03 | 2012-01-24 | Kythera Biopharmaceuticals, Inc. | Formulations of deoxycholic acid and salts thereof |
GB2480632A (en) | 2010-05-25 | 2011-11-30 | Kythera Biopharmaceuticals Inc | Preparation of 12-keto and 12-alpha-hydroxy steroids |
US10150792B2 (en) | 2010-11-08 | 2018-12-11 | Synthonics, Inc. | Bismuth-containing compounds, coordination polymers, methods for modulating pharmacokinetic properties of biologically active agents, and methods for treating patients |
MX363465B (es) | 2011-02-18 | 2019-03-25 | Kythera Biopharmaceuticals Inc | Tratamiento de la grasa submental. |
US8653058B2 (en) | 2011-04-05 | 2014-02-18 | Kythera Biopharmaceuticals, Inc. | Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits |
EP2755480B1 (en) * | 2011-09-16 | 2021-03-31 | Galectin Therapeutics Inc. | Galacto-rhamnogalacturonate compositions for the treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease |
DK2758060T3 (en) * | 2011-09-19 | 2018-03-05 | Eth Zuerich | ROR gamma modulators for the treatment of diabetes II complications |
EP2606747A1 (en) * | 2011-12-22 | 2013-06-26 | Nutrinova Nutrition Specialties & Food Ingredients GmbH | Sweetness enhancer, sweetener compositions, and consumables containing the same |
CN103169650A (zh) * | 2012-03-28 | 2013-06-26 | 沈阳津昌制药有限公司 | 抗流感糖浆及其制备方法 |
BR112014030534A2 (pt) | 2012-06-06 | 2017-06-27 | Galectin Therapeutics Inc | composições de galacto-ramnogalacturonato para o tratamento de doenças associadas com óxido nítrico sintase induzível elevada |
KR102064890B1 (ko) * | 2013-10-22 | 2020-02-11 | 삼성전자 주식회사 | 내부 및 외부 메모리를 선택적으로 사용하는 harq 데이터 처리 장치 및 그 처리 방법 |
CN104546695A (zh) * | 2013-10-25 | 2015-04-29 | 北京韩美药品有限公司 | 一种孟鲁司特钠口服液体制剂及其制备方法 |
EP3082428A4 (en) | 2013-12-09 | 2017-08-02 | Respira Therapeutics, Inc. | Pde5 inhibitor powder formulations and methods relating thereto |
NO2723977T3 (pt) | 2014-03-19 | 2018-03-10 | ||
CN114224829A (zh) | 2014-06-27 | 2022-03-25 | 玫帝托克斯股份有限公司 | 用于减少脂肪的胆酸类与盐类的制剂及用途 |
WO2016070082A1 (en) | 2014-10-31 | 2016-05-06 | University Of Utah Research Foundation | Compositions and methods for bile acid particles |
IL293439A (en) * | 2016-02-29 | 2022-07-01 | Tel Hashomer Medical Res Infrastructure & Services Ltd | Use of bile acids and bile salts as antibacterial agents to prevent conjugation and horizontal transfer of genes in bacteria |
KR20180036580A (ko) * | 2016-09-30 | 2018-04-09 | 주식회사 유스바이오팜 | 수가용화(水加溶化)된 우르소데옥시콜산을 함유하는 염증성 피부질환 또는 중증 소양증 예방 또는 치료용 조성물 |
CN106619670A (zh) * | 2016-12-17 | 2017-05-10 | 郑州郑先医药科技有限公司 | 一种治疗胃痛的西药组合物 |
KR102252450B1 (ko) * | 2017-02-09 | 2021-05-14 | 주식회사 아미코젠파마 | 우르소데옥시콜산을 함유하는 시각장애 예방 또는 치료용 조성물 |
US9989519B1 (en) * | 2017-05-04 | 2018-06-05 | Clayton Pharmaceuticals, LLC | Method for determining in vitro bioequivalence of a sucralfate suspension sample to a sucralfate suspension reference listed drug (RLD) |
CN110730656B (zh) * | 2017-06-02 | 2022-09-16 | 特一华制药株式会社 | 水难溶性成分增溶胶束及含有该胶束的液体制剂 |
CN108685919A (zh) * | 2018-07-23 | 2018-10-23 | 卡梅德生物科技(天津)有限公司 | 奥美拉唑用于制备肝癌干细胞抑制剂的应用 |
KR102111346B1 (ko) * | 2019-08-20 | 2020-05-22 | 아영창 | 침전으로부터 안정한 소듐디옥시콜레이트를 포함하는 수용액상 조성물 |
EP4021492A4 (en) * | 2019-08-30 | 2023-09-06 | Emory University | USE OF DEOXYCHOLIC ACID, DERIVATIVES OR SALTS THEREOF TO FIGHT BACTERIAL INFECTIONS AND ASSOCIATED COMPOSITIONS |
WO2022060121A1 (ko) * | 2020-09-18 | 2022-03-24 | 주식회사 아미코젠파마 | 수가용화된 담즙산을 포함하는 패혈증, 급성 폐손상 질환, 또는 급성 호흡곤란증후군의 예방 또는 치료용 약학 조성물 |
Family Cites Families (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3845770A (en) | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
US3916899A (en) | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
US4320146A (en) | 1978-03-17 | 1982-03-16 | The Johns Hopkins University | Treatment of hepatic and renal disorders with ornithine and arginine salts of branched chain keto acids |
JPS5522616A (en) * | 1978-08-04 | 1980-02-18 | Tokyo Tanabe Co Ltd | Bile acid inclusion compound and injection containing the same |
US4327725A (en) | 1980-11-25 | 1982-05-04 | Alza Corporation | Osmotic device with hydrogel driving member |
IT1210874B (it) * | 1982-04-15 | 1989-09-29 | Istituto Chemioterapico | Sale di magnesio dell'acido chenodesossicolico e dell'acido ursodesossicolico, processo per lasua preparazione e composizioni terapeutiche che lo contengono come principio attivo. |
IT1152801B (it) * | 1982-08-17 | 1987-01-14 | Proter Spa | Composti steroidei ad attivita' coleretica, processo per la loro preparazione e composizioni terapeutiche che li contengono come principio attivo |
GB8313217D0 (en) | 1983-05-13 | 1983-06-22 | Glaxo Group Ltd | Pharmaceutical compositions |
GB8417895D0 (en) | 1984-07-13 | 1984-08-15 | Marples B A | Pharmaceutical anti-fungal composition |
JPS62153220A (ja) * | 1985-12-27 | 1987-07-08 | Tokyo Tanabe Co Ltd | 胆汁酸内用水剤 |
US4999287A (en) * | 1988-05-19 | 1991-03-12 | Chemtrak Corporation | Direct measuring assay strip and method of use thereof |
HU203204B (en) | 1987-09-15 | 1991-06-28 | Sandoz Ag | Process for producing suppository containing calcitonin and taurocholic acid |
CA1336401C (en) | 1987-10-15 | 1995-07-25 | Brian H. Vickery | Intranasal administration of polypeptides in powdered form |
US5446026A (en) | 1989-08-09 | 1995-08-29 | Advanced Peptides & Biotechnology Sciences | Potent non-opiate analgesic |
US5157022A (en) | 1989-11-22 | 1992-10-20 | Adrian Barbul | Method for reducing blood cholesterol using arginine |
EP0527153B1 (en) | 1990-04-04 | 1996-07-24 | Berwind Pharmaceutical Services, Inc. | Aqueous maltodextrin and cellulosic polymer film coatings |
US5057321A (en) | 1990-06-13 | 1991-10-15 | Alza Corporation | Dosage form comprising drug and maltodextrin |
US5269011A (en) * | 1990-09-24 | 1993-12-07 | Emc Corporation | Dynamically reconfigurable data storage system with storage system controllers selectively operable as channel adapters on storage device adapters |
IT1245889B (it) | 1991-04-12 | 1994-10-25 | Alfa Wassermann Spa | Formulazioni farmaceutiche per uso orale gastroresistenti contenenti sali di acidi biliari. |
IT1245890B (it) | 1991-04-12 | 1994-10-25 | Alfa Wassermann Spa | Formulazioni farmaceutiche per uso orale gastroresistenti contenenti acidi biliari. |
IT1245891B (it) | 1991-04-12 | 1994-10-25 | Alfa Wassermann Spa | Formulazioni farmaceutiche a rilascio controllato per uso orale gastroresistenti contenenti acidi biliari e loro sali. |
CH680704A5 (pt) | 1991-05-15 | 1992-10-30 | Medichemie Ag | |
HU209251B (en) | 1992-03-13 | 1994-04-28 | Synepos Ag | Process for producing stable, peroral solution drug forms with controlled release of active ingredient and comprising beta-blocking pharmacons |
GB9212511D0 (en) * | 1992-06-12 | 1992-07-22 | Cortecs Ltd | Pharmaceutical compositions |
US5302400A (en) | 1992-06-22 | 1994-04-12 | Digestive Care Inc. | Preparation of gastric acid-resistant microspheres containing digestive enzymes and buffered-bile acids |
US5260074A (en) | 1992-06-22 | 1993-11-09 | Digestive Care Inc. | Compositions of digestive enzymes and salts of bile acids and process for preparation thereof |
US5578304A (en) | 1992-06-22 | 1996-11-26 | Digestive Care Inc. | Compositions of digestive enzymes and salts of bile acids and process for preparation thereof |
US5977070A (en) * | 1992-07-14 | 1999-11-02 | Piazza; Christin Teresa | Pharmaceutical compositions for the nasal delivery of compounds useful for the treatment of osteoporosis |
AU683049B2 (en) | 1993-03-31 | 1997-10-30 | Mitsubishi-Tokyo Pharmaceuticals, Inc. | Cholestasis ameliorant |
CA2167537A1 (en) | 1993-07-19 | 1995-02-02 | Tsuneo Ozeki | Hepatitis c virus proliferation inhibitor |
DE59407041D1 (de) * | 1993-08-30 | 1998-11-12 | Medichemie Ag | Ursodeoxycholsäure enthaltendes Arzneimittel in flüssiger Darreichungsform |
JP3288550B2 (ja) * | 1994-05-02 | 2002-06-04 | オーバーシーズ ファーマテック株式会社 | ヘリコバクター・ピロリ菌殺菌のための局所用口腔内投与剤 |
DE4432708A1 (de) | 1994-09-14 | 1996-03-21 | Hoechst Ag | Modifizierte Gallensäuren, Verfahren zu ihrer Herstellung und ihre Verwendung |
US5653987A (en) | 1995-05-16 | 1997-08-05 | Modi; Pankaj | Liquid formulations for proteinic pharmaceuticals |
DE19523204A1 (de) * | 1995-06-27 | 1997-01-02 | Hoechst Ag | Pulverförmige Pigmentzubereitung |
US5686588A (en) | 1995-08-16 | 1997-11-11 | Yoo; Seo Hong | Amine acid salt compounds and process for the production thereof |
US5843929A (en) | 1996-03-22 | 1998-12-01 | Mayo Foundation For Medical Education And Research | Chemoprevention of metachronous adenomatous colorectal polyps |
AU2540397A (en) | 1996-03-22 | 1997-10-10 | Mayo Foundation For Medical Education And Research | Combinations of an ursodeoxycholic acid compound and a nsaid for the chemopreventive protection of the colorectum |
DE29717252U1 (de) | 1997-09-26 | 1998-02-19 | Dr. Falk Pharma GmbH, 79108 Freiburg | Arzneimittelkit aus einem Budesonid-haltigen und einem Ursodesoxycholsäure-haltigen Arzneimittel zur Behandlung von cholestatischen Lebererkrankungen |
KR100572090B1 (ko) * | 1998-02-24 | 2006-04-17 | 액티브 바이오틱스 인코포레이티드 | 상승작용이 있는 항균제 조성물, 그것을 함유하는 의약 및 소화기질환 치료제, 그들의 제조 방법, 및 그에 관련된 제제 |
RU2224523C2 (ru) * | 1998-07-24 | 2004-02-27 | Сео Хонг Ю | Водный раствор, содержащий желчную кислоту, и способ его получения |
-
2001
- 2001-02-05 WO PCT/US2001/003745 patent/WO2001056547A2/en active IP Right Grant
- 2001-02-05 EP EP01908862A patent/EP1255566A2/en not_active Withdrawn
- 2001-02-05 AU AU3668501A patent/AU3668501A/xx active Pending
- 2001-02-05 JP JP2001556239A patent/JP2004500378A/ja active Pending
- 2001-02-05 KR KR1020027009885A patent/KR100848344B1/ko not_active IP Right Cessation
- 2001-02-05 BR BR0108080-6A patent/BR0108080A/pt not_active Application Discontinuation
- 2001-02-05 CN CNB018045499A patent/CN100558407C/zh not_active Expired - Fee Related
- 2001-02-05 IL IL15095201A patent/IL150952A0/xx unknown
- 2001-02-05 CA CA2406930A patent/CA2406930C/en not_active Expired - Fee Related
- 2001-02-05 RU RU2002123352/14A patent/RU2277913C2/ru not_active IP Right Cessation
- 2001-02-05 AU AU2001236685A patent/AU2001236685B2/en not_active Ceased
-
2002
- 2002-07-29 IL IL150952A patent/IL150952A/en not_active IP Right Cessation
- 2002-12-04 US US10/309,603 patent/US7166299B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN100558407C (zh) | 2009-11-11 |
IL150952A0 (en) | 2003-02-12 |
JP2004500378A (ja) | 2004-01-08 |
RU2002123352A (ru) | 2004-03-27 |
AU2001236685B2 (en) | 2006-05-18 |
AU3668501A (en) | 2001-08-14 |
CN1450914A (zh) | 2003-10-22 |
RU2277913C2 (ru) | 2006-06-20 |
WO2001056547B1 (en) | 2003-02-20 |
KR100848344B1 (ko) | 2008-07-25 |
EP1255566A2 (en) | 2002-11-13 |
US20030186933A1 (en) | 2003-10-02 |
CA2406930C (en) | 2011-02-15 |
IL150952A (en) | 2010-11-30 |
CA2406930A1 (en) | 2001-08-09 |
US7166299B2 (en) | 2007-01-23 |
KR20020084109A (ko) | 2002-11-04 |
WO2001056547A2 (en) | 2001-08-09 |
WO2001056547A3 (en) | 2002-07-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0108080A (pt) | Preparação de formas de dosagem de solução clara aquosa com ácidos biliares | |
BR9912395A (pt) | Preparação de formas de dosagem de solução clara aquosa com ácidos biliares | |
BRPI0419213A (pt) | formas secas de formulação de dosagem de ácido biliar solubilizada aquosa: preparação e usos destas | |
HRP20130071T1 (hr) | Poboljšani testosteron u gelu i naäśin primjene | |
ES2228507T3 (es) | Composiciones herbicidas mejoradas. | |
BRPI0417947A (pt) | composto, composição farmacêutica, fabricação de um medicamento para o uso no tratamento e/ou prevenção de um metabólico distúrbio, e, formulação farmacêutica | |
BR112012004051A8 (pt) | formulação de concentrado aquoso, uso da formulação de concentrado aquoso e metodo para controlar vegetação indesejada | |
BR0007533A (pt) | Composições adjuvante e pesticida, e, processopara eliminar ou controlar ervas daninhas | |
RU2008135945A (ru) | Вирулицидные композиции и их применение | |
BR0309743A (pt) | Processo para a preparação de gama-butirolactamas e gama-aminoácidos altamente funcionalizados | |
BR0214430A (pt) | Formulação de aminoácidos e riboflavina úteis para reduzir efeitos tóxicos de quimioterapia citotóxica | |
RU2009137380A (ru) | Лиофилизированный препарат, содержащий гриппозную вакцину, и способ его получения | |
BR0110892A (pt) | Forma de administração farmacêutica para peptìdios, processos para preparação e uso dos mesmos | |
HRP20150120T1 (hr) | Materijal i metode za lijeäśenje poremeä†aja u razvoju ukljuäśujuä†i komorbidni i idiopatski autizam | |
BR0313727A (pt) | Derivados de isoquinolina como inibidores de metaloproteinase da matriz | |
HRP20110698T1 (hr) | Kompleks nukleinske kiseline i pripravak za oslobađanje nukleinske kiseline | |
BR9914929A (pt) | Fenil - alquenoil - guanidinas substituìdas de ácido biliar, processos para a sua preparação, sua aplicação como medicamentos ou agentes diagnósticos, assim como medicamento contendo as mesmas | |
BR0307009A (pt) | Sais estáveis de ácido o-acetilsalicìlico com aminoácidos básicos ii | |
BR0006301A (pt) | Macrólidos antibacterianos e pró-cinéticos | |
BR9713466A (pt) | Premix concentrada com inflamabilidade reduzida para formação de composição amaciante de tecido | |
BR9915019A (pt) | Derivados de propanolamina ligados com ácido biliar para o tratamento de distúrbios do metabolismo de lipìdeos | |
BR9810632A (pt) | Processo e composições que promovem a eficácia biológica de substâncias quìmicas exógenas em plantas | |
PE20000271A1 (es) | Composicion farmaceutica de (1s,4r)-cis-4-[2-amino-6-(ciclopropilamino)-9h-purin-9-il]-2-ciclopenteno-1-metanol | |
BR0207077A (pt) | Sais de adição do ácido málico da terbinafina | |
EA200000772A1 (ru) | Фармацевтические композиции и способы их приготовления |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B15K | Others concerning applications: alteration of classification |
Free format text: ALTERADA DA INT.CL: A61K 9/00 Ipc: A61K 31/575 (2010.01), A61K 47/36 (2010.01), A61K |
|
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 10( VIII ), 11, 13, 24 E 25 DA LPI. |
|
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |